Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy

BACKGROUND: To determine whether antibiotic treatment is a risk factor for immune-related adverse events (irAEs) across different patients with cancer receiving anti-PD-1/PD-L1 therapies. METHODS: The retrospective analysis includes clinical information from 767 patients with cancer treated at Hunan...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Ying, Chen, Xue, Li, Kunyan, Liu, Yaoming, Zhang, Zhao, Chen, Yiqing, Liu, Yuan, Wang, Yushu, Lin, Steven H, Diao, Lixia, Wang, Jing, Lou, Yanyan, Johnson, Douglas B, Chen, Xiang, Liu, Hong, Han, Leng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772460/
https://www.ncbi.nlm.nih.gov/pubmed/35058327
http://dx.doi.org/10.1136/jitc-2021-003779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772460/
https://www.ncbi.nlm.nih.gov/pubmed/35058327
http://dx.doi.org/10.1136/jitc-2021-003779

Ejemplares similares